Position in ZURA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$159,111
+$70,451 QoQ
Shares Held
26,968
+81.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#68
of 95 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Forefront Analytics, LLC holds $1,763,485 across 9 Biotechnology names. ZURA ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,091 | $577,115 | |
| 2 | LEGN |
Legend Biotech Corp
|
10,568 | $305,203 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
415 | $258,769 | |
| 4 | ZURA |
Zura Bio Ltd
This page
|
26,968 | $159,111 | |
| 5 | GERN |
Geron Corp
|
88,779 | $113,637 | |
| 6 | CTMX |
CytomX Therapeutics, Inc.
|
25,033 | $93,873 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
|
21,822 | $92,525 | |
| 8 | NKTX |
Nkarta, Inc.
|
28,955 | $81,942 |
All Filings in ZURA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $159,111 | 26,968 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $88,660 | 14,901 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $102,583 | 19,577 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $93,172 | 21,518 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $67,184 | 63,985 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $139,717 | 108,308 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $134,335 | 53,734 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $125,087 | 30,810 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $145,491 | 41,569 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $87,476 | 34,038 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $99,138 | 21,229 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $95,462 | 14,464 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||